Consistent with these effects, GLP-1 RAs have been associated with substantial weight loss in clinical trials, leading to FDA approval of two of these agents liraglutide and semaglutide for chronic weight management in adults with obesity or with overweight and at least one weight-related comorbidity
PMID: 74 PuYLongCYueRZhangBJiangYLiZ
A symptom log gives a clinician more useful information than simply saying, "The medication makes me sick." What GLP-1 Symptoms Require Urgent Medical Attention
Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity
In AD, astrocytes not only take up and clear A plaques but also contribute to disease progression by transforming into reactive astrocytes
Metabolic syndrome and psoriatic arthritis: The role of weight loss as a disease-modifying therapy